SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549


                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                                 AUGUST 23, 2004

                                 Date of Report
                        (Date of earliest event reported)

                       NEW BRUNSWICK SCIENTIFIC CO., INC.

               (Exact Name of Registrant as Specified in Charter)

     NEW  JERSEY                    0-6994                         22-1630072

  (State  or  Other  Jurisdiction  of          (Commission  File  Number)
(IRS  Employer  Identification  No.)
     Incorporation)


          44  TALMADGE  ROAD,  EDISON,  NJ                         08818-4005
       (Address  of  Principal  Executive Offices)                    (ZIP Code)


          Registrant's  telephone  number,  including area code:  (732) 287-1200

          (Former  Name  or  Former  Address,  if  Changed  Since  Last  Report)




1





ITEM  8.01.  OTHER  EVENTS


The following information is furnished pursuant to Item 8.01, "Other Events":



A  restructuring  of  the  management  of  the  operations  carried  on  through
Registrant's  European  subsidiaries  has  resulted  in  the  termination of the
Managing  Director  of  its  European operations.  On August 23, 2004 Registrant
received  an  agreement  signed  by  the  Managing  Director  agreeing  that the
effective date of the Managing Director's termination was July 12, 2004 and that
his  severance  would  be  approximately 281,000 euros (approximately $346,000),
payable  in  a  single  payment.  Registrant  believes  that  the amount of this
severance  payment  will  prove  to  be  material to the Registrant's results of
operations  for  the  quarter  ended  October  2,  2004.





                                      SIGNATURES

     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
Registrant  had  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  hereunto  duly  authorized.


     NEW  BRUNSWICK  SCIENTIFIC  CO.,  INC.

Date:  August  23,  2004                         By:     /s/Samuel  Eichenbaum

                                        Samuel  Eichenbaum
                                        Vice  President,  Finance  and
                                        Chief  Financial  Officer



2